This trial is completed!
Search for a recruiting clinical trial for your condition
Your journey
1What's a trial
4Get in touch
More info
You can access this
clinical trial
if you have
Arthrodesis Surgery Involving the Hindfoot or Ankle
and you are
between 18 and 74
years old
The phase for this study is not defined.
Show me locations

The purpose

To demonstrate that AMPLEX is non-inferior to autogenous bone graft (ABG) for bone fusion in a population indicated for single, double, or triple hindfoot arthrodesis or ankle arthrodesis surgery with supplemental graft material.

Provided treatments

  • Device: AMPLEX®
  • Procedure: Autogenous Bone Graft (ABG)

Locations near you

Unfortunately, there are no recruiting locations near you. Please check the list with all locations below.
Tris trial is registered with FDA with number: NCT03028415. The sponsor of the trial is Ferring Pharmaceuticals and it is looking for 56 volunteers for the current phase.
Official trial title:
A Multi-Center, Randomized, Pivotal Study Evaluating AMPLEX® Compared To Autogenous Bone Graft in Subjects Indicated for Arthrodesis Surgery Involving the Hindfoot or Ankle